Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_assertion type Assertion NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_head.
- NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_assertion description "[To determine if ovarian cancer patients would be suitable for MAGE-peptide vaccine-based immunotherapy, the frequency of expression of the MAGE-1-4 genes in ovarian tumours was assessed using reverse transcription polymerase chain reaction (RT-PCR) and product verification with digoxigenin-labelled oligonucleotide probes specific for each MAGE gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_provenance.
- NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_assertion evidence source_evidence_literature NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_provenance.
- NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_assertion SIO_000772 9743307 NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_provenance.
- NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_assertion wasDerivedFrom befree-20140225 NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_provenance.
- NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_assertion wasGeneratedBy ECO_0000203 NP823287.RA2xpLbyRxC-1FCa1heDFfpZKQfubav6TdGirS8eseHW8130_provenance.